You are here: Industry Insights > J&J

News List

J&J reaches opioid settlement with holdout state New Mexico ExpressPharma
January 17, 2022
Under the accord, J&J agreed to pay New Mexico its share of the nationwide settlement in 2022, rather than over several years, if all of the state’s local governments signed on by 31st May.
J&J agrees to pay $63m to settle opioid claims in Nevada Pharmaceutical-Technology
January 06, 2022
With the agreement announced by Nevada Attorney General Aaron Ford, the company is no longer involved in the opioid litigation.
Oklahoma supreme court overturns ruling against J&J in $465m opioid lawsuit Pharmaceutical-Technology
November 11, 2021
The Oklahoma State Supreme Court in the US has overturned a 2019 judgement that had ruled Johnson & Johnson (J&J) and its Janssen Pharmaceutical Companies accountable for contributing to the opioid crisis.
J&J Says Booster Shot Ups Immune Response to COVID-19 drugs
August 26, 2021
Johnson & Johnson reported Wednesday that a booster shot of its vaccine dramatically raised the levels of antibodies against COVID-19.
When could Moderna, J&J COVID-19 vaccines win full FDA approval? firstwordpharma
August 25, 2021
A spokesperson for Johnson & Johnson says the company plans to file a biologics license application for its single-dose COVID-19 vaccine with the FDA "later in 2021," reported Fox News.
J&J, Theravance's izencitinib fails Phase II ulcerative colitis trial firstwordpharma
August 24, 2021
Shares in Theravance Biopharma tumbled about 22% in after-hours trade on Monday after the company said izencitinib did not meet the primary endpoint of a Phase IIb trial of patients with ulcerative colitis (UC).
Decision on J&J COVID-19 Vaccine Booster Doses Could Take Weeks drugs
August 23, 2021
A decision on booster shots for the approximately 13.8 million Americans who received the Johnson & Johnson single-shot COVID-19 vaccine is likely to take weeks, according to people familiar with the issue.
Changing of the guard at J&J as Joaquin Duato named to top job starting January firstwordpharma
August 20, 2021
Johnson & Johnson said Thursday that long-time CEO and chairman Alex Gorsky will be stepping down from his role and handing over the reins to his deputy, executive committee vice-chairman Joaquin Duato, effective January 3. At that point.
South African activists slam J&J for exporting vaccines firstwordpharma
August 18, 2021
Health activists in Africa have slammed Johnson & Johnson for exporting COVID-19 vaccines produced in South Africa to Europe, as reported in This is Money.
India authorises J&J’s Covid-19 vaccine for emergency use pharmaceutical-technology
August 09, 2021
India has approved Johnson & Johnson’s (J&J) single-dose Covid-19 vaccine for emergency use, expanding the total number of anti-SARS-CoV-2 vaccines authorised in the country to five.

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 Next page